CS CONNECTION
including its QuickScan baseline assessment and Process Ready Analysis. This combines tray utiliation data with work ow and pro- cess observation to develop solutions that streamline inventory and optimie surgical trays, helping to reduce complexity, assem- bly and inspection errors, and decreased bioburden and contamination risks. These best practices are easy to imple- ment and can save the SPD time and money in the long run,” said Schrader. “They can also greatly decrease the risk of sending a set to the OR that has a quality or sterility issue.” To help CPD technicians assemble
surgical instrument sets and packages of individual instruments in a safer, more consistent and more effi cient man- ner, T utomation has developed its Assisted Instrument Management (AIM) line of products. This includes the IM Tray Assembly solution, which uses machine vision (MV) technology and artificial intelligence (AI) to automatically identify and verify instruments on the count sheet; and the AIM Peel Pack tool, which uses MV technology and AI to automatically generate steriliation pouches and labels simultaneously.
instruments assembled and sterilized are available when needed, functional and safe to use on the patient. To accomplish 100 percent accuracy on these three critical factors, SPD management must determine the number of inspections that are neces- sary. These inspections must be conducted by a competent person who was not the person assembling the peel pack or tray. The number of inspected items can change as findings increasedecrease. indings should be documented so that trends can be identifi ed. oth the PD and O must accurately report events for the data to be meaningful. Trend data must then be used as a control tool. Training and process adustments must be applied to prevent errors from occurring.”
and AIM Tray Assembly solution RST Automation
AIM Peel Pack tool
Tracking and reporting errors Gregg Agoston, M.B.A., Vice President, usiness Development, PD Transformation ervices, says his number one recommenda- tion for quality and sterility assurance is to view the CPD as a manufactur- ing process. This means that quality assurances and quality control measures must be integral to C PD operations. goston explains how each C PD must determine an acceptable level of inspections of assembled sets prior to steriliation. The department must also put in place a formal system to track and report on errors discovered. “Based on assessment findings from hospitals across the country, there is sig- nificant need for improvement in C practices, said goston. The goal should always be that 100 percent of the
Gregg Agoston
Proper protection chrader points out the need for hospitals and other healthcare facilities to properly protect their surgical assets during sterilia- tion and transportation to extend instru- ment life and optimie reprocessing. “A tray instrument organization system reduces instrument damage and reduces case delays by making it easy to identify missing andor wrong instruments during preparation, said chrader. During sur- gery, the staff is able to more easily locate the proper instrument. Placing these orga- nied sets in rigid sterile containers helps eliminate case delays related to holes in blue wrap and helps reduce overall sterile packaging processing costs and reprocess- ing time.” The esculap eries terilContainer
2 is .. ood and Drug dministra- tion (D) cleared for low temperature (TD, TI V-PO, TIO), PreVac team and tO steriliation modali- ties. It features an anodied fi nish, and it is easily identifi ed by its gold container handles and lid latches. esculap has a wide variety of baskets, racks and Instru- ment Organization System (IOS) holders to organie and protect instrument sets. It can be used to sterilie pre-confi gured orthopaedic, spine and specialty medical instrument sets.
the hands of the CPD, O staff must also do their part to keep instruments safe and effective. As Ron Banach, Director of Clinical Training for uhof ealthcare, explains, point of use (PO) cleaning of instruments and scopes by clinical staff in procedural areas paves the way for effective cleaning and steriliation in the CPD. eeping instruments moist helps pre-
vent soil (e.g., blood, body uids) from dry- ing and adhering to the instruments,” said Banach. “Dried soil can make instruments more diffi cult to clean and potentially lead to the formation of dry-surface biofi lm. Treating instruments with an enzymatic pretreatment at the point of use can help prevent rusting and corrosion prevent blood, organic materials and debris from drying on the instruments; and inhibit dry-surface biofi lm formation. anach says it is recom-
mended that perioperative personnel use enymatic pre-cleaning humectants and sprays to keep instru- ments and rigid scopes moist, especially those that sit for extended periods of time. One such enzymatic humectant spray is uhofs Prepyme orever et with moisture reten- tion properties lasting up to 2 hours, making
Ruhof’s Prepzyme Forever Wet
cleaning easier and more effective.
Sterilization success ith the onset of the COVID 19 pandemic, one of the biggest challenges facing sup- ply chain and PD professionals was the unpredictable demand for personal protec- tive equipment (PP), mostly notably the supply of 9s, said ulie orog, , , CO, Clinical ducation Consultant Clinical Trainer, dvanced teriliation Products. Due to unpredictability of the impact on hospitaliation admissions, healthcare facilities had to temporarily modify some of their practices that were inconsistent with professional standards and guidelines prior to the COVID-19 pandemic. orog points specifi cally to the Ds Emergency Use Authorization (EUA) for Sterilization Systems.1, 2, 3
This is intended Aesculap JS Series SterilContainers
Point of use (POU) cleaning While quality and sterility assurance of surgical instruments is typically placed in
34 January 2021 • HEALTHCARE PURCHASING NEWS •
hpnonline.com
for decontamination of compatible 9 respirators for single-user reuse by health- care personnel in healthcare facilities to prevent exposure to pathogenic biological airborne particulates during the COVID-19 pandemic. This temporary authoriation was outside the recommended practices of the
Page 36
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58